Struve, N., Brend, T., Stead, L., Binder, Z. A., Ott, L., Muller-Goebel, J., . . . Kriegs, M. (2017). EXTH-52. EGFRvIII: A NEW PREDICTIVE BIOMARKER FOR TEMOZOLOMIDE RESPONSE IN MGMT PROMOTOR METHYLATED GLIOBLASTOMA PATIENTS. Neuro Oncol.
Style de citation ChicagoStruve, Nina, et al. "EXTH-52. EGFRvIII: A NEW PREDICTIVE BIOMARKER FOR TEMOZOLOMIDE RESPONSE IN MGMT PROMOTOR METHYLATED GLIOBLASTOMA PATIENTS." Neuro Oncol 2017.
Style de citation MLAStruve, Nina, et al. "EXTH-52. EGFRvIII: A NEW PREDICTIVE BIOMARKER FOR TEMOZOLOMIDE RESPONSE IN MGMT PROMOTOR METHYLATED GLIOBLASTOMA PATIENTS." Neuro Oncol 2017.
Attention : ces citations peuvent ne pas être correctes à 100%.